Daniel Antonio González Padilla, MD

Daniel A. González Padilla, MD, emphasized that shared decision-making is essential, as patients must weigh potential benefits against adverse effects and the possibility of ultimately requiring radical cystectomy or clinical trial participation.

Although BCG has been the standard of care for decades and remains the most effective available treatment, outcomes remain suboptimal for many patients.